Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David V Jobes

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Biometrics|July 5, 2007
Genome scanning tests for comparing amino acid sequences between groupsPeter B Gilbert, Chunyuan Wu, David V Jobes
Vaccine|October 21, 2006
LC16m8: an attenuated smallpox vaccineJulie Kenner, Fiona Cameron, Cyril Empig, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 30, 2002
BK virus regulatory region rearrangements in brain and cerebrospinal fluid from a leukemia patient with tubulointerstitial nephritis and meningoencephalitisGerald L Stoner, Raj Alappan, David V Jobes, et al.
Molecular Biology and Evolution|October 30, 2009
Phylodynamics of HIV-1 from a phase-III AIDS vaccine trial in North AmericaMarcos Pérez-Losada, David V Jobes, Faruk Sinangil, et al.
Plos One|March 23, 2011
Phylodynamics of HIV-1 from a phase III AIDS vaccine trial in Bangkok, ThailandMarcos Pérez-Losada, David V Jobes, Faruk Sinangil, et al.
Retrovirology|July 17, 2009
Ethnic differences in the adaptation rate of HIV gp120 from a vaccine trialMarcos Pérez-Losada, David Posada, Miguel Arenas, et al.
AIDS Research and Human Retroviruses|October 28, 2006
High incidence of unusual cysteine variants in gp120 envelope proteins from early HIV type 1 infections from a Phase 3 vaccine efficacy trialDavid V Jobes, Melissa Daoust, Vivian Nguyen, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2014
The novel immunotherapeutic oligodeoxynucleotide IMT504 protects neutropenic animals from fatal Pseudomonas aeruginosa bacteremia and sepsisAbdullah Chahin, Steven M Opal, Jorge Zorzopulos, et al.
The Journal of General Virology|April 12, 2001
Genotypes of JC virus in East, Central and Southwest EuropeHansjürgen T Agostini, Alison Deckhut, David V Jobes, et al.
AIDS Research and Human Retroviruses|October 28, 2006
Longitudinal population analysis of dual infection with recombination in two strains of HIV type 1 subtype B in an individual from a Phase 3 HIV vaccine efficacy trialDavid V Jobes, Melissa Daoust, Vivian T Nguyen, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Biometrics|July 5, 2007
Genome scanning tests for comparing amino acid sequences between groupsPeter B Gilbert, Chunyuan Wu, David V Jobes
Vaccine|October 21, 2006
LC16m8: an attenuated smallpox vaccineJulie Kenner, Fiona Cameron, Cyril Empig, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 30, 2002
BK virus regulatory region rearrangements in brain and cerebrospinal fluid from a leukemia patient with tubulointerstitial nephritis and meningoencephalitisGerald L Stoner, Raj Alappan, David V Jobes, et al.
Molecular Biology and Evolution|October 30, 2009
Phylodynamics of HIV-1 from a phase-III AIDS vaccine trial in North AmericaMarcos Pérez-Losada, David V Jobes, Faruk Sinangil, et al.
Plos One|March 23, 2011
Phylodynamics of HIV-1 from a phase III AIDS vaccine trial in Bangkok, ThailandMarcos Pérez-Losada, David V Jobes, Faruk Sinangil, et al.
Retrovirology|July 17, 2009
Ethnic differences in the adaptation rate of HIV gp120 from a vaccine trialMarcos Pérez-Losada, David Posada, Miguel Arenas, et al.
AIDS Research and Human Retroviruses|October 28, 2006
High incidence of unusual cysteine variants in gp120 envelope proteins from early HIV type 1 infections from a Phase 3 vaccine efficacy trialDavid V Jobes, Melissa Daoust, Vivian Nguyen, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2014
The novel immunotherapeutic oligodeoxynucleotide IMT504 protects neutropenic animals from fatal Pseudomonas aeruginosa bacteremia and sepsisAbdullah Chahin, Steven M Opal, Jorge Zorzopulos, et al.
The Journal of General Virology|April 12, 2001
Genotypes of JC virus in East, Central and Southwest EuropeHansjürgen T Agostini, Alison Deckhut, David V Jobes, et al.
AIDS Research and Human Retroviruses|October 28, 2006
Longitudinal population analysis of dual infection with recombination in two strains of HIV type 1 subtype B in an individual from a Phase 3 HIV vaccine efficacy trialDavid V Jobes, Melissa Daoust, Vivian T Nguyen, et al.
Pageof 2